Cat.#: ACPP-1432
| Despition | NENF Human Recombinant |
| SIZE | 2 µg |
| Purity | Purity as determined by densitometric image analysis is > 95%. |
| Form | Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1041 | Recombinant Human Wnt3a Protein (AC1041) | 50 µg | inquiry |
| ACPP-1273 | BTB/POZ domain-containing protein 7 Blocking Peptide (AC1273) | 250 µg | inquiry |
| ACPP-1201 | HAND2 Blocking Peptide (AC1201) | 250 µg | inquiry |
| ACPP-1059 | Recombinant Human ALK Protein (Fc Tag) (AC1059) | 50 µg | inquiry |
| ACPP-1163 | Recombinant Human GFAP Protein (Fc Tag) (AC1163) | 50 µg | inquiry |
| ACPP-1155 | Recombinant Human PCDH18 Protein (6×His Tag) (AC1155) | 50 µg | inquiry |
| ACPP-1519 | Human MANF Protein (AC1519) | 5 µg | inquiry |
| ACPP-1648 | Human RAMP1 Protein (AC1648) | 2 µg | inquiry |
| ACPP-1205 | Human MECP2 Protein (AC1205) | 2 µg | inquiry |
| ACPP-1106 | Recombinant Human c-Kit Protein (6×His Tag) (AC1106) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.